These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 14519750)

  • 1. Enhancing radiotherapy with cyclooxygenase-2 enzyme inhibitors: a rational advance?
    Choy H; Milas L
    J Natl Cancer Inst; 2003 Oct; 95(19):1440-52. PubMed ID: 14519750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potential of selective cyclooxygenase-2 inhibitors in the management of tumor angiogenesis.
    Gately S; Kerbel R
    Prog Exp Tumor Res; 2003; 37():179-92. PubMed ID: 12795055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of a COX-2 inhibitor with radiotherapy or radiochemotherapy in the treatment of thoracic cancer.
    Liao Z; Milas L; Komaki R; Stevens C; Cox JD
    Am J Clin Oncol; 2003 Aug; 26(4):S85-91. PubMed ID: 12902863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of tumor response to radiation or chemoradiation by selective cyclooxygenase-2 enzyme inhibitors.
    Nakata E; Mason KA; Hunter N; Husain A; Raju U; Liao Z; Ang KK; Milas L
    Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):369-75. PubMed ID: 14751505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase-2 (COX-2) enzyme inhibitors and radiotherapy: preclinical basis.
    Milas L
    Am J Clin Oncol; 2003 Aug; 26(4):S66-9. PubMed ID: 12902859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of radiotherapy or chemoradiotherapy by targeting COX-2 enzyme.
    Milas L; Mason KA; Crane CH; Liao Z; Masferrer J
    Oncology (Williston Park); 2003 May; 17(5 Suppl 5):15-24. PubMed ID: 12800601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New chemotherapeutic agents: update of major chemoradiation trials in solid tumors.
    Curran WJ
    Oncology; 2002; 63 Suppl 2():29-38. PubMed ID: 12466642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of radiation and celebrex (celecoxib) reduce mammary and lung tumor growth.
    Liu W; Chen Y; Wang W; Keng P; Finkelstein J; Hu D; Liang L; Guo M; Fenton B; Okunieff P; Ding I
    Am J Clin Oncol; 2003 Aug; 26(4):S103-9. PubMed ID: 12902866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclooxygenase-2: a novel target for cancer chemotherapy?
    Dempke W; Rie C; Grothey A; Schmoll HJ
    J Cancer Res Clin Oncol; 2001 Jul; 127(7):411-7. PubMed ID: 11469677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COX-2 inhibitor as a radiation enhancer: new strategies for the treatment of lung cancer.
    Saha D; Pyo H; Choy H
    Am J Clin Oncol; 2003 Aug; 26(4):S70-4. PubMed ID: 12902860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors.
    Masferrer JL; Leahy KM; Koki AT; Zweifel BS; Settle SL; Woerner BM; Edwards DA; Flickinger AG; Moore RJ; Seibert K
    Cancer Res; 2000 Mar; 60(5):1306-11. PubMed ID: 10728691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo.
    Liu XH; Kirschenbaum A; Yao S; Lee R; Holland JF; Levine AC
    J Urol; 2000 Sep; 164(3 Pt 1):820-5. PubMed ID: 10953162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COX-2 inhibitors as radiosensitizing agents for cancer therapy.
    Davis TW; Hunter N; Trifan OC; Milas L; Masferrer JL
    Am J Clin Oncol; 2003 Aug; 26(4):S58-61. PubMed ID: 12902857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: Enhancement of tumor response to gamma-radiation by an inhibitor of cyclooxygenase-2 enzyme.
    Gallo O
    J Natl Cancer Inst; 2000 Feb; 92(4):346-7. PubMed ID: 10675387
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo.
    Leahy KM; Ornberg RL; Wang Y; Zweifel BS; Koki AT; Masferrer JL
    Cancer Res; 2002 Feb; 62(3):625-31. PubMed ID: 11830509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo.
    Sawaoka H; Tsuji S; Tsujii M; Gunawan ES; Sasaki Y; Kawano S; Hori M
    Lab Invest; 1999 Dec; 79(12):1469-77. PubMed ID: 10616198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial experience combining cyclooxygenase-2 inhibition with chemoradiation for locally advanced pancreatic cancer.
    Crane CH; Mason K; Janjan NA; Milas L
    Am J Clin Oncol; 2003 Aug; 26(4):S81-4. PubMed ID: 12902862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of COX-2 inhibition in breast cancer treatment and prevention.
    Arun B; Goss P
    Semin Oncol; 2004 Apr; 31(2 Suppl 7):22-9. PubMed ID: 15179621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase-2: a therapeutic target in angiogenesis.
    Iñiguez MA; Rodríguez A; Volpert OV; Fresno M; Redondo JM
    Trends Mol Med; 2003 Feb; 9(2):73-8. PubMed ID: 12615041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COX-2 inhibition and lung cancer.
    Sandler AB; Dubinett SM
    Semin Oncol; 2004 Apr; 31(2 Suppl 7):45-52. PubMed ID: 15179623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.